- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06495762
Preventing Premature Family Maladjustment: an e-Health Interdisciplinary Research (e-ParWelB)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Brief statement of primary study objectives and the main secondary study objectives.
The e-ParWelB project is an interdisciplinary study which, starting from the premises of the ParWelB project, aims to evaluate the well-being of preterm parents during and after hospitalization in the Neonatal Intensive Care Unit NICU using research strategies such as standardized questionnaires with internationally validated scales and psychological support with an innovative and technology-driven approach. Recently scholars have supported the use of Web-App-based support programs to monitor and prevent maladjustment of preterm families and assist parents who have difficulty transitioning from the NICU to home (Sawyer et al., 2019; Greene et al., 2020). Furthermore, the work of Garfield et al. (2016) with very low birth weight infants demonstrated that parents who received an app-based support program improved self-efficacy and their perception of preparedness for discharge.
Starting from these premises, the main objectives of our research can be summarised as follows: (1) monitor the mental health of parents of children born prematurely, with a six-month follow-up to prevent family maladjustment ; (2) deepen knowledge on the role of digital tools in monitoring and supporting the mental health of parents whose infants have been admitted to neonatal intensive care for critical health situations such as prematurity.
Brief statement of primary study outcome and primary estimand/estimator. Then describe the main secondary study outcome measures.
Considering the time and economic resources available, we estimate to intercept the families of approximately 175 children born preterm, thus roughly a sample of 350 participants.
The validated scales employed will be used to create statistical indices measuring concepts such as levels of stress, depression, parental self-efficacy and perception of social support received from parents. These variables will be correlated through statistical processing and modelling with independent socio-demographic variables (gender, age, nationality, ...), and indicators of economic, social and cultural capital.
The research assumes to find statistically significant differences in the levels of stress, anxiety and self-efficacy with respect to sample segmentations related to gender, educational background and migration variables.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Alessandra Decataldo, PhD
- Phone Number: +39 0264487418
- Email: alessandra.decataldo@unimib.it
Study Locations
-
-
CA
-
Cagliari, CA, Italy, 09123
- Dipartimento Materno infantile, Terapia Intensiva Neonatale, Azienda Ospedaliero-Universitaria di Cagliari
-
Contact:
- Vassilios Fanos
- Phone Number: +39 07051093403
- Email: vafanos@tiscali.it
-
-
MB
-
Monza, MB, Italy, 20900
- S.C. Neonatologia e Terapia Intensiva Neonatale, I.R.C.C.S. Ospedale San Gerardo Monza
-
Contact:
- Maria Luisa Ventura
- Phone Number: +39 030392331
- Email: marialuisa.ventura@irccs-sangerardo.it
-
-
MI
-
Milano, MI, Italy, 20132
- U.O Neonatologia e Patologia Neonatale, I.R.C.C.S. Ospedale San Raffaele
-
Contact:
- Antonella Poloniato
- Phone Number: 02 26432623
- Email: poloniato.antonella@hsr.it
-
-
PV
-
Pavia, PV, Italy, 27100
- S.C. Neonatologia e Terapia Intensiva Neonatale, Fondazione IRCCS Policlinico San Matteo di Pavia.
-
Contact:
- Camilla Pisoni
- Phone Number: +39 0382502518
- Email: pisoni.camilla@gmail.com
-
-
TV
-
Treviso, TV, Italy, 31100
- U.O.C. di Terapia Intensiva Neonatale, patologia neonatale ed assistenza al neonato sano presso il Presidio Ospedaliero di Treviso
-
Contact:
- Paola Lago
- Phone Number: +39 0422322263
- Email: paola.lago@aulss2.veneto.it
-
-
VI
-
Vicenza, VI, Italy, 36100
- UOSD di Terapia Intensiva e Patologia Neonatale presso l'ospedale di Vicenza (ULSS 8 Berica).
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Parents of children born before 36+6 of gestational age (GA).
- The parents must be at least 18 years old
- Children must have been hospitalized in intensive or sub-intensive care for at least ten days.
- Parents must be able to speak fluent Italian or English.
Exclusion Criteria:
- Children must not have other genetic pathologies or other pathologies not linked to the preterm birth.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postpartum Anxiety
Time Frame: The scale is administered 3 times: the day of child discharge from NICU (starting from 01/09/2024 to 28/02/2025), 30 days after child's discharge (from 01/10/2024 to 28/03/2025) and 180 days after child's discharge (from 01/03/2024 to 28/09/2025).
|
Measured through Postpartum Specific Anxiety Scale (PSAS).
Most of the literature on postpartum anxiety (Glasheen, Richardson, & Fabio, 2010; Lostein, 2007; Meades & Ayers, 2011) refers to measures of generalised anxiety which can often prove problematic from a psychometric point of view.
To date, the only questionnaire available that specifically measures postpartum anxiety is the Postpartum Specific Anxiety Scale (PSAS).
The instrument also demonstrated excellent psychometric properties (ω between 0.72 and 0.90 in the four scales and λ4 between 0.71 and 0.92 in the four scales).
For these reasons, the research team believed it was the most sensitive and suitable tool for capturing the construct under investigation in the target population (parents of children born preterm).
|
The scale is administered 3 times: the day of child discharge from NICU (starting from 01/09/2024 to 28/02/2025), 30 days after child's discharge (from 01/10/2024 to 28/03/2025) and 180 days after child's discharge (from 01/03/2024 to 28/09/2025).
|
|
Post-partum PTSD
Time Frame: The scale is administered 2 times: the day of child discharge from NICU (starting from 01/09/2024 to 28/02/2025) and 90 days after child's discharge (from 01/12/2024 to 28/05/2025).
|
Measured through City Birth Trauma Scale (City BiTS).
The scale is an instrument specifically developed to measure birth-related post-traumatic stress disorder according to the recent DSM-5 criteria and is, to the authors' knowledge, the only instrument with this specificity.
This instrument has previously demonstrated excellent reliability (Cronbach's a = 0.92).
For these reasons, the research team believed it was the most sensitive and suitable tool for capturing the construct under investigation in the target population (parents of children born preterm).
|
The scale is administered 2 times: the day of child discharge from NICU (starting from 01/09/2024 to 28/02/2025) and 90 days after child's discharge (from 01/12/2024 to 28/05/2025).
|
|
Post-partum depression
Time Frame: The scale is administered 2 times: the day of child discharge from NICU (starting from 01/09/2024 to 28/02/2025) and 90 days after child's discharge (from 01/12/2024 to 28/05/2025).
|
Measured through Edinbugh Postnatal Depression Scale (EPDS).
Postnatal depression is the most widely measured disorder in the postpartum population which in Italy is mostly subject to routine checks.
The Edinburgh Postnatal Depression Scale (EPDS) is the most widely used self-report questionnaire to measure postpartum depression given the simplicity of administration, ease of cultural adaptation and excellent psychometric properties demonstrated.
The validated Italian version demonstrated good validity and reliability (Cronbach's α =0.7894), confirming the validity of the EPDS in identifying postnatal depression.
|
The scale is administered 2 times: the day of child discharge from NICU (starting from 01/09/2024 to 28/02/2025) and 90 days after child's discharge (from 01/12/2024 to 28/05/2025).
|
|
Post-partum parent-child bonding
Time Frame: The scale is administered once, the day of child discharge from NICU (starting from 01/09/2024 to 28/02/2025).
|
Measured through Postpartum Bonding Questionnaire (PBQ) (in T0).
The scale aims to measure the quality of the bond between parents and children and identify if there are problems in the relationship.
The Italian adaptation of the PBQ, edited by Rosario Montirosso, Claudia Fedeli, Livio Provenzi and Ian Brockington was developed using the back-translation procedure (Montirosso et al., 2009).
Studies show that the Italian version of the PBQ has good psychometric properties and can be implemented in the Italian cultural context to assess early mother-child relational difficulties (Busonera et al., 2017).
|
The scale is administered once, the day of child discharge from NICU (starting from 01/09/2024 to 28/02/2025).
|
|
Parenting-related stress
Time Frame: The scale is administered 3 times: 30 days after child's discharge from NICU (from 01/10/2024 to 28/03/2025), 60 days after child's discharge from NICU (from 01/11/2024 to 28/04/2025) and 180 days after child's discharge (from 01/03/2024 to 28/09/2025).
|
Measured through Parenting Stress Index (PSI).
The literature on existing research has highlighted the possibility of identifying stressful "child-parent" systems early in order to develop interventions aimed at reducing stress that can reduce the frequency and the intensity of emotional and behavioral disorders of children in our society (Cash et al., 2006; van Ijzendoorn et al., 2005).
The Parenting Stress Index (PSI) was developed in response to the need for a measure to assess these characteristics.
|
The scale is administered 3 times: 30 days after child's discharge from NICU (from 01/10/2024 to 28/03/2025), 60 days after child's discharge from NICU (from 01/11/2024 to 28/04/2025) and 180 days after child's discharge (from 01/03/2024 to 28/09/2025).
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Alessandra Decataldo, PhD, University of Milano Bicocca
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 20225R7XB3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychological Distress
-
Universita di VeronaUniversity of Roma La SapienzaRecruitingDistress, Emotional | Distress, PsychologicalItaly
-
Utah State UniversityCompletedPsychological Distress | Psychological Flexibility | Psychological Well-BeingUnited States
-
Universidad de las Americas - QuitoRecruitingPsychological DistressEcuador
-
Barbel KnauperNot yet recruitingPsychological DistressCanada
-
Fondation Santé des Étudiants de FranceRecruitingPsychological DistressFrance
-
Fondazione IRCCS Policlinico San Matteo di PaviaCompletedPsychological DistressItaly
-
Azienda Unita Sanitaria Locale di PiacenzaUniversity of Siena, ItalyCompleted
-
International Islamic University MalaysiaCompletedPsychological DistressSingapore
-
George Washington UniversityWorld Health Organization; Transcultural Psychosocial Organization Nepal; Socios... and other collaboratorsCompletedPsychological DistressNepal, Peru, Uganda
-
University of LincolnLincolnshire Partnership NHS Foundation TrustCompletedPsychological DistressUnited Kingdom
Clinical Trials on e-health assesment
-
Yale UniversityCompletedObesity | Type 2 DiabetesUnited States
-
Philips Electronics Nederland B.V. acting through...Medisch Spectrum TwenteWithdrawn
-
American University of Beirut Medical CenterCompleted
-
Central Hospital, Nancy, FranceUniversity of Lorraine; Cnam-ISTNARecruitingOverweight and ObesityFrance
-
Dokuz Eylul UniversityCompletedThoracic Surgery | Preoperative Care | E-health | Education of Patients | E-health AppTurkey (Türkiye)
-
University of CagliariAlessandra PerraCompletedBipolar Disorder | COVID-19 Pandemic | PsychoeducationItaly
-
Stony Brook UniversityCompletedStress | Anxiety | Depressive Symptoms | ImpairmentUnited States
-
University of RochesterRobert Wood Johnson Foundation; United States Department of CommerceCompletedCommon Childhood Illnesses | Non-emergent CareUnited States
-
National University of MalaysiaRecruitingBreast Cancer | Breast Neoplasms | Depression, Anxiety | Distress, EmotionalMalaysia
-
Pennington Biomedical Research CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | OverweightUnited States